Global News

EOSE Stock Slides As Legal Probes Cloud Outlook

Eos Energy Enterprises Inc. (EOSE) stock has fallen significantly due to negative technology and funding headlines, exacerbated by multiple legal probes into potential corporate wrongdoing. Securities litigation firms are investigating the company on behalf of investors who bought shares before November 5, 2025, focusing on disclosures and governance during that period. The ongoing investigations create persistent headline risk, contributing to the stock's downtrend despite some liquidity, as the company faces massive losses and high cash burn.

Read more

Stifel reiterates Hold on VF Corp stock, keeps $17 price target By Investing.com

Stifel maintained its "Hold" rating on VF Corp (NYSE:VFC) and reiterated a $17 price target, noting the stock is currently undervalued according to InvestingPro. The firm's Q2 fiscal 2027 adjusted EPS estimate is $0.54, slightly above consensus, with investor sentiment largely tied to Vans wholesale orders, though The North Face and Timberland are performing well. The risk/reward balance is seen as balanced, and VF Corp. has maintained dividend payments for 56 consecutive years.

Read more

LOTTE Biologics and Alvotech Forge Long-Term Partnership to Expand Global Biosimilar Manufacturing Capacity

LOTTE Biologics and Alvotech have announced a long-term strategic manufacturing partnership to expand global biosimilar manufacturing capacity. LOTTE Biologics will manufacture drug substance for multiple antibody biosimilar products at its 40,000-liter Syracuse facility in New York, strengthening Alvotech's US manufacturing footprint and global supply network. This collaboration aims to meet the growing demand for biosimilars and ensure a reliable supply of high-quality, affordable biologic medicines worldwide.

Read more

Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

NanoViricides announced that its Phase IIA clinical trial for NV-387 Oral Gummies, a treatment for Ebola Bundibugyo virus, is progressing well in the Democratic Republic of Congo. The trial focuses on safety and tolerability across different disease severities, with efficacy signals to be observed if NV-387 proves highly effective against the 67-75% infection-to-fatality rate of this Ebola strain. NV-387 is a broad-spectrum antiviral designed to mimic host-side features essential for viral entry, making it potentially effective against various Ebola strains and other viruses.

Read more

EXCLUSIVE: Guyana may scale back LNG plans as Exxon needs more gas for its wells, sources say

Guyana is considering scaling back its plans for liquefied natural gas (LNG) production and exports because ExxonMobil needs more offshore gas to maximize its oil production. Exxon and its partners anticipate requiring about 2 billion cubic feet per day of gas for reinjection into oilfields, which would limit the gas available for export projects, potentially shrinking a proposed LNG facility from 6 mtpa to 3 mtpa. This development could impact Guyana's ambitions to become a regional energy powerhouse and is causing frustration among potential investors.

Read more

Marvell Technology, Kulicke and Soffa, Vishay Intertechnology, Allegro MicroSystems, and Amkor Shares Plummet, What You Need To Know

Shares of Marvell Technology, Kulicke and Soffa, Vishay Intertechnology, Allegro MicroSystems, and Amkor fell following reports of Chinese design breakthroughs in memory technology that could loosen tight supplies sooner than expected. Additionally, comments from Broadcom CEO Hock Tan cautioning against irrational AI investment sentiment contributed to the market's reassessment of semiconductor and memory manufacturers. Vishay Intertechnology, despite being up 102% year-to-date, saw its shares drop, reflecting investor concerns.

Read more

Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73

Nurix Therapeutics, Inc. (NRIX) announced its Q3 earnings, reporting an EPS of $4.73, a significant increase from ($1.03) in the previous year. The company's revenue for the quarter also saw substantial growth, reaching $673.1 million compared to $7.9 million last year. This positive financial performance is a key highlight for the biopharmaceutical company.

Read more

Form 144 CARLSMED For: 12 October By Investing.com

This article from Investing.com reports the filing of Form 144 for CARLSMED on October 12, 2026. Form 144 is a notice of the intent to sell restricted securities. The article provides this information without further elaboration, along with current market data for various indices, commodities, and shares.

Read more

NextEra Energy (NEE) Is Cheaper Than Its Past. Is the Wait Worth It?

NextEra Energy (NEE) is trading at a lower valuation than its historical average, despite strong adjusted earnings growth and a robust backlog of renewable projects. This discount is attributed to the long timeline for its proposed acquisition of Dominion Energy and the delay in securing large data center contracts. The article suggests that while the company's fundamentals remain strong, the wait for these catalysts to materialize requires patience from investors.

Read more

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar's stock rose 4% following a Truist Securities upgrade to Buy with a $270 price target and a Section 232 trade decision setting a 44-cent/watt floor on foreign solar panels starting in December. This policy, which directly benefits First Solar due to its thin-film module manufacturing in the U.S., creates a clear distinction between winners and losers in the solar sector, leaving companies like Enphase Energy and Sunrun relatively flat. The analyst believes this tariff floor will provide a stronger pricing backdrop for First Solar into the 2030s, although near-term pricing is already locked in, meaning the full benefits may not be seen for several years.

Read more

Moët Hennessy, Analog Devices and UC Davis Join Forces to Advance Wine Production Through Breakthrough Chemical Signature Detection Technology Leveraging AI

Moët Hennessy, Analog Devices, and UC Davis have partnered to develop a new AI-powered technology for enhancing wine quality and supporting vineyard vitality. This breakthrough allows for the early detection of complex chemical signatures in grapes and wine, predicting quality risks like Fresh Mushroom Aroma faster and more affordably than traditional methods. The technology aims to provide viticulture and winemaking teams with earlier insights and decision-support tools, with potential future applications including disease detection and soil assessment.

Read more

Take-Two Interactive Slides 5% as Wells Fargo Trims Estimates Behind $300 Target; Roblox Holds Flat, GameStop Barely Budges

Take-Two Interactive (NASDAQ: TTWO) shares dropped 5% after Wells Fargo maintained its "Overweight" rating and $300 price target but cut near-term estimates due to weak basketball and mobile unit assumptions. Despite the revisions, Wells Fargo's bullish stance is driven by high expectations for Grand Theft Auto VI, set to launch November 19, overshadowing current challenges. Other gaming stocks like Roblox and GameStop remained largely unaffected, indicating the selloff is specific to Take-Two.

Read more

CVS to pay $315 million to settle unlawful opioid prescription claims, Justice Department says

CVS has agreed to pay $315 million to settle allegations that it illegally filled unlawful opioid prescriptions. The U.S. Justice Department announced the settlement, stating that CVS submitted false claims to the federal government by seeking payment from Medicare and other healthcare programs.

Read more

Is Occidental Petroleum Stock A Good Fit For Your Portfolio?

This article analyzes Occidental Petroleum (OXY) stock's performance relative to the broader market, noting its recent tendency to move inversely to the S&P 500. It highlights OXY's higher volatility compared to the S&P 500 and points out that despite outpacing the index in returns over five years, its price swings offered about half the return per unit of swing. The piece concludes that OXY remains primarily an oil price bet, offering a counterbalance to a portfolio only if oil and gas are not already significant holdings.

Read more

VRSK Maintained by Morgan Stanley -- Price Target Lowered to $21

Morgan Stanley analyst Toni Kaplan maintained an Equal-Weight rating for Verisk Analytics (VRSK), lowering its price target from $235.00 to $215.00, an 8.51% decrease. Despite this, GuruFocus considers VRSK significantly undervalued with a GF Value™ of $326.28 against its current price of $176.88, and it holds a strong GF Score™ of 83/100, though insider selling activity and lower financial strength warrant caution.

Read more

EVRG Maintained by BMO Capital -- Price Target Lowered to $85

BMO Capital maintained an Outperform rating for Evergy Inc. (EVRG) but lowered its price target from $89.00 to $85.00, reflecting a cautious outlook due to market conditions and regulatory challenges. GuruFocus indicates EVRG is approximately 20.1% overvalued with a GF Value™ of $68.06 compared to its current price of $81.73, despite a strong GF Score™ of 81/100 and positive insider buying activity. Investors are advised to proceed with caution due to concerns about its financial strength and valuation.

Read more

Deadline Alert: GoDaddy Inc. (GDDY) Shareholders Who Lost

Glancy Prongay Wolke & Rotter LLP is reminding investors of GoDaddy Inc. (NYSE: GDDY) about an upcoming October 20, 2026 deadline to file as lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that GoDaddy made misleading statements between September 3, 2025, and February 24, 2026, regarding its business operations and a promotional discount strategy that negatively impacted bookings and revenue. Investors who suffered losses on GoDaddy securities during this period are urged to contact the law firm to learn about potentially recovering their losses.

Read more

Community health takes a village: Screening in the barber’s chair

Novartis is collaborating with community organizations like the African American Male Wellness Agency (AAMWA) through its Inclusive Health Accelerator (IHA) model to bring health screenings and information directly to trusted community spaces. This initiative, which focuses on breast and prostate cancer care, aims to overcome healthcare barriers by engaging people in familiar environments like barbershops, making health conversations and screenings more accessible and effective. The program seeks to combine clinical expertise with local knowledge to create sustainable pathways to care, expanding to over 30 countries by 2030.

Read more

Form FWP BANK OF AMERICA CORP Filed by: BANK OF AMERICA CORP /DE/

This FWP filing by Bank of America Corp details the terms of new Market Linked Securities—Auto-Callable with Contingent Coupon, linked to the performance of Micron Technology, Amazon.com, and Eli Lilly common stocks. The securities offer contingent coupon payments with a memory feature and have contingent downside principal at risk, meaning investors could lose a significant portion or all of their principal. The document outlines the payout profile, various risk considerations, and regulatory information for potential investors.

Read more

Delaware jury awards Qualcomm $2 in damages, finds Arm breached license agreement

A Delaware jury has ruled that Arm Holdings breached a licensing agreement with Qualcomm and intentionally interfered with Qualcomm's business relationship with Meta Platforms. Qualcomm was awarded nominal damages of $2. The verdict followed a five-day trial, marking the second such legal battle between the companies, highlighting a deteriorating relationship since SoftBank acquired Arm in 2016.

Read more

Qualcomm Statement on Trial Verdict Win

Qualcomm has issued a statement regarding a trial verdict win. The statement likely provides details about the legal victory and its implications for the company.

Read more

45,000 Shares of Medtronic PLC $MDT Bought by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC recently purchased 45,000 shares of Medtronic PLC (NYSE:MDT) valued at approximately $3.9 million, making it a significant holding in their portfolio. This move aligns with a generally positive outlook from institutional investors, who collectively own 82.06% of the company. Despite some analyst target reductions and increased short interest, Medtronic exceeded recent earnings expectations and maintains a stable dividend, indicating a potential for price recovery.

Read more

Arista Networks, Inc. $ANET Shares Newly Purchased by McGlone Suttner Wealth Management Inc.

McGlone Suttner Wealth Management Inc. has acquired 19,913 shares of Arista Networks (NYSE:ANET) for approximately $4.05 million, making it their 26th largest position. This comes as Arista Networks reports strong quarterly results with a 37.7% year-over-year revenue increase and beats EPS estimates, despite significant insider selling totaling $706.4 million over the past 90 days. Analysts maintain a "Moderate Buy" consensus with a $235.45 target price, noting the stock's high P/E ratio of 64.25.

Read more

J&J's 6% slide on an imperfect quarter is a gift to prospective buyers

Johnson & Johnson's shares fell 6% after an "imperfect" quarter, despite revenue and adjusted EPS exceeding expectations. The slide is seen as a buying opportunity for long-term investors due to strong performance in the Innovative Medicine segment, particularly with the new psoriasis drug Icotyde, and a robust product pipeline. While the medical devices business faced challenges, the company's pharmaceutical growth and future outlook, including potential double-digit growth by the end of the decade, reinforce a "buy" rating.

Read more

26,570 Shares of Edison International $EIX Bought by Steel Grove Capital Advisors LLC

Steel Grove Capital Advisors LLC recently acquired 26,570 shares of Edison International (NYSE:EIX) valued at approximately $1.43 million, increasing institutional ownership of the utility provider. Despite this, analyst sentiment remains cautious, with a consensus "Reduce" rating and an average price target of $60.18. Edison International shares have fallen to $52.44, near their 12-month low, even as the company announced a quarterly dividend of $0.8775, representing a 6.7% annualized yield.

Read more

Hasbro notifies R.I. officials nearly 600 jobs to leave the state ahead of move to Boston in 2027

Hasbro has notified Rhode Island officials that nearly 600 jobs will leave the state as the company moves its operations to Boston in 2027. While all 587 affected employees have been offered positions at the new Boston office, their employment will end in December 2026 if they do not accept the relocation. Pawtucket Mayor Donald R. Grebien expressed disappointment in Hasbro's lack of engagement with local officials regarding the move and its implications for the city and its employees.

Read more

Goldman Sachs Maintains Loar Holdings(LOAR.US) With Buy Rating, Cuts Target Price to $99

Goldman Sachs has reiterated its Buy rating on Loar Holdings (LOAR.US) but has adjusted its price target downwards from $105 to $99. This adjustment indicates a continued positive outlook on the company despite a revised valuation.

Read more

Form 4 Lattice Semiconductor Corporation: Pravin Desale (SVP, R&D) For: 10 October

This article reports on a Form 4 filing for Lattice Semiconductor Corporation (LSCC) concerning Pravin Desale, the SVP of R&D, for October 10. Form 4 filings disclose changes in ownership of company stock by insiders. The article indicates a specific date for the filing but does not provide further details about the transaction.

Read more

20,793 Shares of Best Buy Co., Inc. $BBY Purchased by Sage Capital Advisors llc

Sage Capital Advisors llc has acquired 20,793 shares of Best Buy Co., Inc. (NYSE:BBY) worth approximately $1.84 million in the third quarter. This purchase contributes to the 80.96% institutional ownership of BBY, while the company recently reported strong quarterly earnings and pays a 4.4% annual dividend. Despite a consensus "Hold" rating from analysts with an average price target of $85.65, the stock is trading above its 200-day moving average, though two insiders recently sold a significant number of shares.

Read more

AI Boom Faces a Trillion-Dollar Financing Test, Goldman Sachs CEO Warns

Goldman Sachs CEO David Solomon highlighted AI as a major growth opportunity but warned that the immense financing required for AI infrastructure could strain borrowing costs and jeopardize projects. He noted that despite rising 10-year Treasury yields

Read more

NioCorp strengthens Project Vault link

NioCorp has finalized a definitive agreement with Traxys, securing a buyer for half of its planned ferroniobium production and giving Traxys exclusive rights to purchase all scandium, titanium, and rare earth products from the Elk Creek mine. This agreement strengthens NioCorp's connection to the U.S. strategic critical minerals reserve, Project Vault, and is a significant step towards securing financing for the mine's development. The deal precedes a high-profile visit to Elk Creek by federal and state officials, including EXIM Chairman John Jovanovic, who is finalizing due diligence for potential debt financing.

Read more

What Explains the Latest Low for Morgan Stanley Direct Lending Fund (NYSE:MSDL)?

Morgan Stanley Direct Lending Fund (NYSE:MSDL) recently hit a new annual trading low, reflecting market weakness despite its business model of providing senior secured loans to middle-market companies. The fund reported quarterly earnings that were in line with consensus and declared a regular distribution, which is a key feature for business development companies. Its performance is influenced by credit market conditions, financing costs, and borrower finances, rather than conventional operating businesses.

Read more

Franklin Templeton's tokenized high yield bond ETF FLHYon launches on Pendle with 2026 maturity.

Franklin Templeton has launched FLHYon, a tokenized version of its high yield corporate bond ETF (FLHY), on Pendle, in partnership with Ondo Finance, offering economic exposure without direct share ownership and backed 1:1 by underlying assets. This new token, with a 2026 maturity, allows investors to trade future yield streams, providing new liquidity options. While it introduces innovative trading mechanisms, potential risks include credit risk, issuer risk, and smart contract vulnerabilities, and it currently holds a modest $497,000 in on-chain assets.

Read more

Steel Grove Capital Advisors LLC Makes New $5.63 Million Investment in Citizens Financial Group, Inc. $CFG

Steel Grove Capital Advisors LLC has made a new $5.63 million investment in Citizens Financial Group (CFG), acquiring 88,373 shares in the third quarter. This makes CFG the 26th largest holding for the firm, accounting for 0.4% of its portfolio. Analysts have a "Moderate Buy" consensus for CFG, with an average price target of $79.38, significantly above its recent trading price of $63.10.

Read more

U.S. rocket-motor capacity investment tops $500M. Lockheed Martin will access a share of Avio's capacity.

Lockheed Martin and Avio have formed a strategic cooperation agreement to boost the production of solid rocket motors, with Avio investing over $500 million in new U.S. production capacity. This collaboration aims to strengthen the U.S. industrial base for solid rocket motors, ensuring supply chain resiliency and accelerating the manufacturing of critical munitions like ER GMLRS and PrSM. The agreement will allow Lockheed Martin to access Avio's supply capacity, meeting increased customer demand and supporting mission readiness.

Read more

PayPal Stock Is Up Nearly 7% in October. Here’s Where It Could Go by 2030

PayPal's stock has risen nearly 7% in October, closing at $56.05. This surge comes despite CEO Enrique Lores lowering expectations for branded checkout growth, with the upcoming third-quarter report on October 27 set to reveal if shares have outpaced these revised forecasts. TIKR's analysis suggests PayPal could reach around $87 by 2030, representing a 55% potential return or about 11% annually, based on conservative revenue and EPS growth assumptions.

Read more

JPMorgan reports more than 2 million Middleby (MIDD) shares in its passive stake.

JPMorgan Chase & Co. has reported a 4.5% passive stake in The Middleby Corporation (MIDD), owning 2,051,817 shares of common stock as of September 30, 2026. This information comes from a Schedule 13G/A amendment filing with the SEC, indicating JPMorgan's sole voting power over 1,943,511 shares and sole dispositive power over 2,051,166 shares. The filing lists several JPMorgan subsidiaries as entities with beneficial ownership.

Read more

NextEra Energy (NEE) Receives a Buy from Wells Fargo

Wells Fargo analyst Shahriar Pourreza maintained a Buy rating on NextEra Energy (NEE) with a $108.00 price target. This comes after NextEra Energy reported a strong Q2 earnings, with revenue of $7.53 billion and a net profit of $3.14 billion, an increase from the previous year. Other analysts have offered mixed ratings, with BMO Capital issuing a Buy and Mizuho Securities maintaining a Hold.

Read more

Arista Networks, Inc. $ANET Stock: Steel Grove Capital Advisors LLC Grows Position

Steel Grove Capital Advisors LLC significantly increased its stake in Arista Networks (NYSE:ANET) by 2,399.5% in the third quarter, now holding 38,992 shares valued at approximately $7.94 million. The company has reported strong operating momentum with revenue up 37.7% year-over-year to $3.04 billion and EPS of $1.02, surpassing estimates. Despite a positive outlook from analysts and high demand expectations driven by AI, the stock has seen a 3.3% decline amidst valuation and insider selling concerns.

Read more

Centene Corp stock hits 52-week high at 69.64 USD By Investing.com

Centene Corp's stock has reached a new 52-week high of $69.64, driven by a robust 90.56% one-year change and a "GREAT" financial health score. Analysts from Argus, Cantor Fitzgerald, and Bernstein SocGen Group have reiterated positive ratings and price targets, citing potential for margin improvements and strategic initiatives. InvestingPro analysis suggests the stock, with a $34.4 billion market capitalization, may still be undervalued.

Read more

Sivik Global Healthcare LLC Makes New Investment in Moderna, Inc. $MRNA

Sivik Global Healthcare LLC has acquired a new position in Moderna (NASDAQ:MRNA), purchasing 10,000 shares valued at approximately $1.93 million, making it 1.2% of their portfolio. Despite this new investment, analysts generally maintain a "Hold" rating with an average price target significantly below the current trading price. The article also notes recent insider selling by Moderna executives and highlights both potential upside from new vaccine developments and ongoing valuation concerns.

Read more

HST Maintained by Barclays -- Price Target Raised to $25.00

Barclays has maintained an Equal-Weight rating for Host Hotels & Resorts (HST) while raising its price target to $25.00. Despite this positive analyst outlook, GuruFocus indicates HST is currently overvalued by 14.0% with a GF Value™ of $20.06. The company holds a strong GF Score™ of 78/100, but significant insider selling worth $2,797,760 in the last three months suggests caution for potential investors.

Read more

Deere & Company $DE Stake Boosted by Fragasso Financial Advisors Inc

Fragasso Financial Advisors Inc. significantly increased its stake in Deere & Company (NYSE:DE) by 160.3% in the third quarter, bringing its total holdings to 2,731 shares worth approximately $1.7 million. This move is part of a broader trend of institutional investors boosting their positions in Deere, which now sees 68.58% institutional ownership. Deere recently reported strong quarterly earnings of $5.10 per share, surpassing estimates, and a 6.2% year-over-year revenue increase to $12.61 billion, alongside a declared quarterly dividend of $1.62 per share.

Read more

MSCI (NYSE:MSCI) Given New $662.00 Price Target at Morgan Stanley

Morgan Stanley has lowered its price target for MSCI (NYSE:MSCI) to $662.00 from $700.00 but maintained an "overweight" rating, suggesting a potential upside of 17.47%. Despite slightly missing Q3 earnings and revenue estimates, analyst sentiment remains positive with a consensus "Buy" rating and an average price target of $705.92. The company's stock currently has a market capitalization of $40.97 billion and a P/E ratio of 30.83.

Read more

7,196 Cheniere Energy, Inc. $LNG Shares Sold by Kieckhefer Group LLC

Kieckhefer Group LLC reduced its stake in Cheniere Energy, Inc. by 43.1% in the third quarter, selling 7,196 shares and retaining 9,514 shares valued at $2.56 million. Despite this sale, Cheniere Energy's stock rose 1.1% to $285.69, nearing its 52-week high, and institutional investors collectively own 87.26% of the company. Analysts maintain a "Buy" rating with an average price target of $306.47, following a quarter where the company reported strong revenue growth but missed EPS estimates.

Read more

69,479 Shares in Cheniere Energy, Inc. $LNG Bought by McCollum Christoferson Group LLC

McCollum Christoferson Group LLC recently purchased 69,479 shares of Cheniere Energy, Inc. (NYSE:LNG), valued at approximately $18.7 million, making it their 9th largest holding. Other institutional investors have also adjusted their positions in Cheniere, with collective institutional ownership now at 87.26%. Cheniere Energy reported strong quarterly revenue growth of 23.5% year-over-year but missed earnings per share estimates, yet analysts maintain a generally positive "Buy" rating with a consensus price target of $306.47.

Read more

9,102 Merck & Co., Inc. $MRK Shares Acquired by Fragasso Financial Advisors Inc

Fragasso Financial Advisors Inc. significantly increased its stake in Merck & Co., Inc. (MRK) during the third quarter by acquiring an additional 9,102 shares, bringing its total holdings to 21,523 shares valued at approximately $3.13 million. Institutional investors collectively hold 76.07% of MRK, while corporate insiders recently sold a substantial amount of shares. Despite insider selling and a slight dip in stock price, Merck exceeded its quarterly EPS and revenue expectations, maintains a "Moderate Buy" rating from analysts, and offers a quarterly dividend.

Read more

1,350 Costco Wholesale Corporation $COST Shares Acquired by First County Bank CT

First County Bank CT significantly increased its stake in Costco Wholesale Corporation, purchasing 1,350 additional shares and bringing its total holdings to 4,309 shares valued at $3.92 million. This move highlights continued institutional interest in Costco, despite some analyst concerns about its elevated valuation. The retailer recently exceeded quarterly earnings expectations with strong EPS and revenue figures, and analysts maintain a "Moderate Buy" consensus with an average price target of $1,046.27.

Read more

Advanced Micro Devices, Inc. $AMD Stock Purchased by Sax Wealth Advisors LLC

Sax Wealth Advisors LLC significantly increased its stake in Advanced Micro Devices (AMD) by 1,262.3% in the third quarter, now owning 75,636 shares valued at $46.3 million. This comes as AMD demonstrates strong quarterly results and growth potential in AI, despite insider stock sales totaling over $105 million in the last 90 days. The article also highlights institutional ownership, analyst ratings, and the company's financial performance, while noting valuation concerns and competition in the chip sector.

Read more

Huntington Ingalls Industries (NYSE:HII) Hits New 1-Year Low - Here's What Happened

Huntington Ingalls Industries (NYSE:HII) stock hit a new 52-week low of $255.55, trading below its 50-day and 200-day moving averages. Despite the decline, analysts maintain a "Moderate Buy" consensus with an average price target of $364.62. The company recently reported stronger-than-expected quarterly results, with $5.27 EPS and $3.42 billion in revenue, and continues to pay a quarterly dividend of $1.38, yielding 2.1%.

Read more